- HOME
- Research
- Researcher's Profile
- Tsuyoshi OSAWA
Researcher's Profile
- Associate Professor
- Tsuyoshi OSAWA
- Integrative Nutriomics and Oncology
Biography
August 2001 | BSc. Medical Biochemistry, King's College London |
---|---|
January 2010 | Ph.D.,Cancer Institute, University College London |
January 2006 | Researcher, Department of Genetics, Institute of Medical Science, The University of Tokyo (UTokyo) |
April 2007 | Assistant Professor, Department of Oncology, Graduate School of Medicine and Dentistry, Tokyo Medical and Dental University |
April 2011 | Research Associate, RCAST, UTokyo |
March 2018 | Project Associate Professor, RCAST, UTokyo |
April 2023 | Associate Professor, RCAST, UTokyo |
Research Interests
Based on the conventional nutritional notion, carbohydrates, lipids and amino acids were independently considered in cancer. However, recent researches in cancer metabolism have been dramatically improved our metabolic knowledge of these disorders due to latest understanding of cancer metabolism. Indeed, carbohydrates, lipids and amino acids are inter-connected in the metabolic pathways, through the several key metabolic molecules such as acetyl-CoA and ketone body intermediates partly under epigenetic regulation. Our group reported that hypoxia, nutrient starvation, acidic pH may induce tumor aggressiveness by epigenetic regulation in cancer cells. We found that epigenetic and metabolic changes influence cancer progression, that can be utilizes for the development of novel therapies by integration of genome, epigenome, transcriptome, proteome, metabolome analysis.Our research objectives:
(1)To identify novel onco-metabolites (cancer associated metabolites) for the treatment of cancer.
(2)To understand the mechanism of cancer adaptation in carbohydrate/lipids/amino acids deficiency and apply it to therapy.
(3)Latest understanding of “nutriomics” for treatment of cancer. We challenge to develop therapeutics for metastasis and recurrent advanced cancer through the viewpoint of integrative “multiomics” approach.
(1)To identify novel onco-metabolites (cancer associated metabolites) for the treatment of cancer.
(2)To understand the mechanism of cancer adaptation in carbohydrate/lipids/amino acids deficiency and apply it to therapy.
(3)Latest understanding of “nutriomics” for treatment of cancer. We challenge to develop therapeutics for metastasis and recurrent advanced cancer through the viewpoint of integrative “multiomics” approach.
Keywords
Cancer Metabolism, Systems Biology, Vascular Biology
Educational Systems
- Department of Advanced Interdisciplinary Studies, Graduate School of Engineering
- Department of Chemistry and Biotechnology, Graduate School of Enginnering